Peer Review History

Original SubmissionNovember 28, 2023
Decision Letter - Dickens Akena, Editor

PONE-D-23-39367The effect of behavioral activation play therapy in adolescents with depression: a study protocol for a randomized controlled trialPLOS ONE

Dear Dr. Zhou,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 12 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Dickens Akena, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: 

"This study was supported by Science and Technology Program of Guangzhou (grant No. 205171098044), Guangzhou Municipal Key Discipline in Medicine (2021-2023), Guangzhou High-level Clinical Key Specialty, and Guangzhou Research-oriented Hospital."

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 

5. We note that the original protocol file you uploaded contains a confidentiality notice indicating that the protocol may not be shared publicly or be published. Please note, however, that the PLOS Editorial Policy requires that the original protocol be published alongside your manuscript in the event of acceptance. Please note that should your paper be accepted, all content including the protocol will be published under the Creative Commons Attribution (CC BY) 4.0 license, which means that it will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution.

Therefore, we ask that you please seek permission from the study sponsor or body imposing the restriction on sharing this document to publish this protocol under CC BY 4.0 if your work is accepted. We kindly ask that you upload a formal statement signed by an institutional representative clarifying whether you will be able to comply with this policy. Additionally, please upload a clean copy of the protocol with the confidentiality notice (and any copyrighted institutional logos or signatures) removed.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

The reviewers have provided their comments. You will need to address their comments and re-submit.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Partly

Reviewer #2: Partly

********** 

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: No

Reviewer #2: Yes

********** 

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

********** 

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Area of review Comment

• What are the main claims of the paper and how significant are they for the discipline?

1. Randomized Controlled Trial (RCT) Design: The RCT is a strong study design for determining the efficacy of interventions. However, the success of an RCT largely depends on its execution, including randomization methods, blinding, and control of confounding factors.

2. Single-blind Approach: The study used a single-blind approach, in which outcome assessors were unaware of the group assignment. Although this helps reduce bias, it is not as robust as a double-blind design. In interventions involving physical activity, double-blinding is challenging, but a single-blind design may still introduce bias.

3. Sample Size and Population: A sample size of 200 adolescents appears adequate, but it is important to consider whether this sample is representative of the broader adolescent population, which is not clearly stated in the article.

4. Intervention Complexity: The integration of BA and GPA could add complexity to the intervention, which might impact its replicability in different settings or practicality in routine clinical practice.

Potential Limitations and Areas for Improvement

1. Follow-Up Duration: The long-term effects of BAPT are not clear from the abstract. A longer follow-up period would be beneficial for assessing the sustainability of treatment effects.

2. Comparison with Existing Treatments: The study compared BAPT with BA only, and not with other standard treatments such as CBT or medication. These comparisons provide a clearer picture of BAPT's relative efficacy of BAPT.

3. Measurement of Outcomes: The Reliance on self-reported measures for some outcomes could introduce bias. Objective measures, where feasible, would strengthen this study's findings.

4. Consideration of Confounding Variables: Adolescent depression can be influenced by numerous social, environmental, and genetic factors. This study accounted for these potential confounders in the analysis.

Implications and Significance

1. Innovative Approach: This study's focus on integrating gamified physical activities into behavioural activation therapy is innovative and could lead to more engaging treatment modalities for adolescents.

2. Potential Clinical Impact: If BAPT is effective, it could offer a valuable tool for treating adolescent depression, potentially improving adherence and outcomes.

3. Contribution to the Field: This research could contribute significantly to the understanding of non-pharmacological interventions in adolescent mental health, an area that requires more empirical data.

While this study presents an innovative approach that has the potential to make significant contributions to the field of adolescent mental health, it is essential to carefully consider its design, execution, and potential limitations. These results should be interpreted within the context of these factors to understand the true efficacy and applicability of BAPT.

• Are the claims properly placed in the context of the previous literature? Have the authors treated the literature fairly?

Comparative Analysis: This study could be strengthened by explicitly comparing the proposed BAPT method with existing treatments in terms of efficacy, side effects, and adherence rates.

Broader Literature Scope: Depending on the full content of the paper, it would be beneficial to include a wider range of studies, particularly those with opposing viewpoints or results, to provide a more comprehensive view of the current state of research.

Longitudinal Studies and Meta-Analyses: The inclusion and discussion of longitudinal studies or meta-analyses in the field would provide deeper insights into the long-term effectiveness of treatments for adolescent depression

• Do the data and analyses fully support the claims? If not, what other evidence is required?

No data sets have been described

• PLOS ONE encourages authors to publish detailed protocols and algorithms as supporting information online. Do any particular methods used in the manuscript warrant such treatment? If a protocol is already provided, for example for a randomized controlled trial, are there any important deviations from it? If so, have the authors explained adequately why the deviations occurred? The authors must provide a detailed guide on how recruitment will be performed and explain how the fidelity, feasibility, and acceptability of the intervention will be achieved.

• If the paper is considered unsuitable for publication in its present form, does the study itself show sufficient potential that the authors should be encouraged to resubmit a revised version?

Upon addressing any outstanding queries and incorporating the responses, this paper will be deemed suitable for publication.

• Are original data deposited in appropriate repositories and accession/version numbers provided for genes, proteins, mutants, diseases, etc.?

None seen

• Does the study conform to any relevant guidelines such as CONSORT, MIAME, QUORUM, STROBE, and the Fort Lauderdale agreement?

Yes, it conforms to CONSORT

• Are details of the methodology sufficient to allow the experiments to be reproduced?

A more in-depth description of the methods is required.

• Is any software created by the authors freely available?

Not mentioned

• Is the manuscript well organized and written clearly enough to be accessible to non-specialists?

With minor edits to the language used, it will be suitable.

• Is it your opinion that this manuscript contains an NIH-defined experiment of Dual Use concern?

It is highly unlikely that this manuscript contains an NIH-defined experiment on dual-use research of concern.

Reviewer #2: "....On the basis of conventional treatment and care, we will 72 compare the outcomes of BAPT and BA. The intervention group and control group will 73 receive nine sessions of BAPT or BA, respectively"

Comment: Since the effect size of BA is already known to be very small, why not have three treatment arms comparing BAPT, BA, and GPA.

You need a dedicated section on ethical considerations in this protocol. Describe in detail how the double vulnerabilities of adolescence and depression will be handled to prevent further harm and how voluntariness will be protected. Also minors cannot give informed consent but rather assent, the protocol only talks about informed consent.

WHO defines adolescents as individuals between ages 10-19. Explain your choice of ages 12-17.

Specialised psychologists will be used to deliver the intervention. How do you eliminate the chances that there is psychological knowledge/skills transfer during the activities, such that at the end of the activities you can be sure that it is indeed BAPT and not interaction with the psychologists (in a novel, play setting) that is causing any effect recorded.

line 261-262: How will you control for the effect of possible psychological intervention received up until the point of hospitalisation and recruitment into the study?

Line 481-482: I think this is an over generalization of adolescents' wishes and preferences. It is assumed here that the adolescents are a homogenous group. Consider having some qualitative interviews with at least some of the participants concerning their views on physical activity.

********** 

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: LYNDA NAKALAWA

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We appreciate the insightful comments provided by the editor and reviewers, and we acknowledge the constructive feedback they have offered. We have submitted three documents in response to the reviewers' comments: a revised manuscript incorporating the suggested changes, a tracked changes document illustrating the revisions made in relation to the original manuscript, and a comprehensive response letter addressing each comment raised by the editor and reviewers. In response to the editor and reviewers' insightful feedback, we have made significant revisions to the manuscript to address their concerns and improve clarity, coherence, and accuracy. The response letter comprehensively addresses each comment raised by the editor and reviewers, providing detailed explanations and clarifications where necessary. We are grateful for the editor and reviewers' dedication and guidance throughout the review process, and we look forward to continued collaboration and refinement of the manuscript.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Dickens Akena, Editor

The effect of behavioral activation play therapy in adolescents with depression: a study protocol for a randomized controlled trial

PONE-D-23-39367R1

Dear Dr. Zhou

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Dickens Akena, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Dickens Akena, Editor

PONE-D-23-39367R1

PLOS ONE

Dear Dr. Zhou,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Dickens Akena

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .